{"id":"W2049260196","doi":"10.1016/j.jcf.2014.12.013","title":"A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients","year":2015,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"University of North Carolina at Chapel Hill; Hospital for Sick Children; University of Washington","keywords":"Medicine; Tobramycin; Levofloxacin; Cystic fibrosis; Inhalation; Exacerbation; Clinical endpoint; Dysgeusia; Adverse effect; Internal medicine; Aztreonam; Pseudomonas aeruginosa; Randomized controlled trial; Anesthesia; Antibiotics; Ceftazidime","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006701646,0.000347313,0.001489994,0.0006858836,0.0001710126,0.000145588,0.0003435066,0.0001778181,0.00004917139],"category_scores_gemma":[0.01827495,0.0002469894,0.000175102,0.001052263,0.000252774,0.0009640557,0.0002598762,0.0004727323,0.00001284552],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008902685,"about_ca_system_score_gemma":0.0007381749,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000331337,"about_ca_topic_score_gemma":0.00005711944,"domain_scores_codex":[0.9937443,0.001343279,0.002215959,0.0003895496,0.001775917,0.0005310214],"domain_scores_gemma":[0.9930321,0.003612954,0.001063992,0.0004126069,0.001391391,0.0004869651],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9452543,0.001764305,0.0001441724,0.0001356398,0.000171093,0.000006187525,0.0009874493,0.001278638,0.03166279,0.00005128502,0.000958859,0.01758526],"study_design_scores_gemma":[0.9422749,0.01618833,0.002897964,0.001165047,0.0006561524,0.00002454208,0.0001878296,0.03269689,0.002753733,0.000382,0.0005218494,0.0002508048],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.960474,0.0009045367,0.03165939,0.001194233,0.0008313621,0.004651782,0.00006634755,0.0000170192,0.0002013189],"genre_scores_gemma":[0.9809443,0.00007547189,0.01844667,0.00003998559,0.0002406269,0.00006721078,0.00008458963,0.00003918642,0.00006196263],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03141825,"threshold_uncertainty_score":0.9999982,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05925007916964949,"score_gpt":0.3767043905778113,"score_spread":0.3174543114081618,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}